MMPR’s Success Can’t Rely On Repeal Of MMAR

There has been much speculation from the financial world in the market potential of the MMPR (Canada’s Marijuana for Medical Purposes Regulation), with investors encouraged by Health Canada’s estimates of some 450,000 potential patients by 2024. But what are these projections based on? It appears Health Canada  has derived their numbers based on the growth of the previous MMAR program, but is this a realistic measure of ‘customer’ growth in this new system?

For example, it’s been over a year now that Tweed (CVE:TWD) has been publicly listed. In June 2014 Tweed broke a $100 million dollar market cap, putting it in the same valuation ballpark as Shopify and Sidney Crosby’s contract with the Pittsburgh Penguins. This has slowly been trickling down to its current market cap at $80 million. Still, $80 million is an excellent valuation for any business. This carries weight across Canadian and American financial markets in support...

Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.


URL: 
http://blog.liftcannabis.ca/2015/05/28/mmpr-success-cant-rely-on-repeal-of-mmar/